{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"glanzmann-thrombasthenia-1","columns":[{"gene":"","key":"population-f5078e381a9d0454861c","label":"Glanzmann thrombasthenia","mondoId":"MONDO:0031332","onsetQualifier":null,"originColumnKey":"MONDO:0031332/OMIM:273800","originalViews":[{"key":"MONDO:0031332/OMIM:273800","label":"Glanzmann thrombasthenia","scopeLabel":"OMIM:273800","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["16e7556b3287aad5606f0b77235671b813dd1b3208f83337e2e23c5bd13c2bba","1708914c3ccd1d5a237d28acaee9f42cade9cb511860bd9344fa3381da50dbd1","2af9f713311f226d420222c6363313a0df477bad19cac5f4540b7750b499d201","43dd78673a31b9d86f84a51bfc784ffbc5ec085ec79d4839469667ad9ed6b2a5","575390d842dfeb65e7e4dcd726477b4ad9df0ac339372883e79227279206cd3b","5a961f9ef5e337ca299c87e8c229fd49b6b1c3de0b4ca938f9cd92fdfaa6230c","7a127a7b04217725f24e773bd1021e5bd312fa7422c3931c74cdd471a56da37f","7c66b86c653a49cf990a5c03a3e334bd46724fdd80f76f74b31eab9e228e1945","7e484effade447ca38cfe654cd08fa042433f3775542f30b18fc58f363fac424","923153e5406d83c1230be3aedec5e2ab5137d5d92491ec8ba674c27ed14b37ad","a3759664102eeef05c6368e1fb10d4248582c45a9eae40d9d6b809bc504c50f6","ac7209acd14c4f112ba6dd5b75206d640c37951a2c55edd4774b36cbd14a06a0","b997bf141324e720709ab48e1f4e377b521d5669c7dbc91c41d848a300d005ad","bd2567a104dff6c64c382602eef1bfbaae919a713bb1aa0508d53e591a0d693e","c29784122b8b307577614461bcb000c7baa96e7bd859a562caff6ad5f5d61ecb","c5818ab8c58dbe8d46de98e9e138f2f8e74a001e6898d5dfad4d8e070f0c5741","d1c4909815fad946afe4020388fb4b03fd4b73f2c223907578a89ba814027248","eeab80e8c26e87bc31cc25c1c895fd5a8f5c41091a9a04b45fc882efb1168d94","fbeeb23d0f8f9c6934d0c076fe189dd3a2bbbbda42dcc3eff510a7afbcc45383"],"recordQualifiers":{},"scopeLabel":"OMIM:273800","sourceIds":["OMIM:273800"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-f5078e381a9d0454861c"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0011873","HP:0000978","HP:0001975","HP:0031364","HP:0000421","HP:0030138","HP:0002239"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":11,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":19,"sourceGroups":{"omim":8,"published":11}},"features":[{"hpoId":"HP:0011873","label":"Abnormal platelet count","primary":true},{"hpoId":"HP:0000978","label":"Bruising susceptibility","primary":true},{"hpoId":"HP:0001975","label":"Decreased platelet glycoprotein IIb-IIIa","primary":true},{"hpoId":"HP:0031364","label":"Ecchymosis","primary":true},{"hpoId":"HP:0000421","label":"Epistaxis","primary":true},{"hpoId":"HP:0030138","label":"Excessive bleeding from superficial cuts","primary":true},{"hpoId":"HP:0002239","label":"Gastrointestinal hemorrhage","primary":true},{"hpoId":"HP:0000225","label":"Gingival bleeding","primary":false},{"hpoId":"HP:0004866","label":"Impaired ADP-induced platelet aggregation","primary":false},{"hpoId":"HP:0031126","label":"Impaired clot retraction","primary":false},{"hpoId":"HP:0008320","label":"Impaired collagen-induced platelet aggregation","primary":false},{"hpoId":"HP:0008148","label":"Impaired epinephrine-induced platelet aggregation","primary":false},{"hpoId":"HP:0003540","label":"Impaired platelet aggregation","primary":false},{"hpoId":"HP:0011871","label":"Impaired ristocetin-induced platelet aggregation","primary":false},{"hpoId":"HP:0002170","label":"Intracranial hemorrhage","primary":false},{"hpoId":"HP:0000132","label":"Menorrhagia","primary":false},{"hpoId":"HP:0003010","label":"Prolonged bleeding time","primary":false},{"hpoId":"HP:0000979","label":"Purpura","primary":false},{"hpoId":"HP:0100309","label":"Subdural hemorrhage","primary":false}],"ledeHtml":"A platelet type bleeding disorder characterized by lifelong mucocutaneous bleeding, markedly impaired platelet aggregation, and absent or severely reduced clot retraction due to failure of the αIIbβ3 integrin complex to bind fibrinogen. Platelets appear normal in number and morphology, but aggregation responses to physiologic agonists (including ADP, collagen, epinephrine, and thrombin) are severely decreased or absent, while ristocetin‑induced agglutination remains normal. Biallelic loss‑of‑function ITGA2B variants reduce or abolish surface expression of the αIIbβ3 receptor, preventing fibrinogen‑mediated platelet bridging and producing the classic Glanzmann thrombasthenia phenotype.","mondoId":"MONDO:0031332","node":{"canonicalSlug":"glanzmann-thrombasthenia-1","comparisons":[{"documentSha256":"5d6473eece949923903a91364bcef79cec9565238c5f74ddb88603172293a6bf","key":"legacy-glanzmann-thrombasthenia","kind":"legacy","label":"Glanzmann thrombasthenia","memberIds":["MONDO:0031009","MONDO:0031332","MONDO:0100326"],"mondoId":"MONDO:0100326","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/glanzmann-thrombasthenia.5d6473eece949923903a91364bcef79cec9565238c5f74ddb88603172293a6bf.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"Glanzmann thrombasthenia 1","paragraphs":["A platelet type bleeding disorder characterized by lifelong mucocutaneous bleeding, markedly impaired platelet aggregation, and absent or severely reduced clot retraction due to failure of the αIIbβ3 integrin complex to bind fibrinogen. Platelets appear normal in number and morphology, but aggregation responses to physiologic agonists (including ADP, collagen, epinephrine, and thrombin) are severely decreased or absent, while ristocetin‑induced agglutination remains normal. Biallelic loss‑of‑function ITGA2B variants reduce or abolish surface expression of the αIIbβ3 receptor, preventing fibrinogen‑mediated platelet bridging and producing the classic Glanzmann thrombasthenia phenotype."],"scope":"exact","source":"MONDO","upstream":"https://clinicalgenome.org/affiliation/40028/, https://orcid.org/0000-0002-7437-8060, PMID:1702098, PMID:9473221","url":"https://monarchinitiative.org/MONDO:0031332"},"ownColumnKeys":["population-f5078e381a9d0454861c"],"publication":"published","relationships":[{"kind":"parent","label":"autosomal recessive disease","mondoId":"MONDO:0006025","slug":null},{"kind":"parent","label":"Glanzmann thrombasthenia","mondoId":"MONDO:0100326","slug":"glanzmann-thrombasthenia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/15240"}],"translation":"pending"},"records":[{"frequencyKind":"count","key":"16e7556b3287aad5606f0b77235671b813dd1b3208f83337e2e23c5bd13c2bba","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0011873","is_excluded":true,"label":"Abnormal platelet count","onset_id":null,"reference":"PMID:8282784","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1708914c3ccd1d5a237d28acaee9f42cade9cb511860bd9344fa3381da50dbd1","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0008320","is_excluded":false,"label":"Impaired collagen-induced platelet aggregation","onset_id":null,"reference":"PMID:8282784","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"2af9f713311f226d420222c6363313a0df477bad19cac5f4540b7750b499d201","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002170","is_excluded":false,"label":"Intracranial hemorrhage","onset_id":null,"reference":"OMIM:273800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"43dd78673a31b9d86f84a51bfc784ffbc5ec085ec79d4839469667ad9ed6b2a5","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"PCS","frequency_raw":"13/13","hpo_id":"HP:0004866","is_excluded":false,"label":"Impaired ADP-induced platelet aggregation","onset_id":null,"reference":"PMID:8282784;PMID:2014236","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"575390d842dfeb65e7e4dcd726477b4ad9df0ac339372883e79227279206cd3b","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000132","is_excluded":false,"label":"Menorrhagia","onset_id":null,"reference":"OMIM:273800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5a961f9ef5e337ca299c87e8c229fd49b6b1c3de0b4ca938f9cd92fdfaa6230c","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002239","is_excluded":false,"label":"Gastrointestinal hemorrhage","onset_id":null,"reference":"OMIM:273800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7a127a7b04217725f24e773bd1021e5bd312fa7422c3931c74cdd471a56da37f","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003540","is_excluded":false,"label":"Impaired platelet aggregation","onset_id":null,"reference":"OMIM:273800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7c66b86c653a49cf990a5c03a3e334bd46724fdd80f76f74b31eab9e228e1945","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000225","is_excluded":false,"label":"Gingival bleeding","onset_id":null,"reference":"OMIM:273800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"7e484effade447ca38cfe654cd08fa042433f3775542f30b18fc58f363fac424","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000421","is_excluded":false,"label":"Epistaxis","onset_id":null,"reference":"PMID:8282784","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"923153e5406d83c1230be3aedec5e2ab5137d5d92491ec8ba674c27ed14b37ad","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"PCS","frequency_raw":"12/12","hpo_id":"HP:0031126","is_excluded":false,"label":"Impaired clot retraction","onset_id":null,"reference":"PMID:2014236","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a3759664102eeef05c6368e1fb10d4248582c45a9eae40d9d6b809bc504c50f6","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0031364","is_excluded":false,"label":"Ecchymosis","onset_id":null,"reference":"PMID:8282784","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ac7209acd14c4f112ba6dd5b75206d640c37951a2c55edd4774b36cbd14a06a0","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0030138","is_excluded":false,"label":"Excessive bleeding from superficial cuts","onset_id":null,"reference":"PMID:8282784","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b997bf141324e720709ab48e1f4e377b521d5669c7dbc91c41d848a300d005ad","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0008148","is_excluded":false,"label":"Impaired epinephrine-induced platelet aggregation","onset_id":null,"reference":"PMID:8282784","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"bd2567a104dff6c64c382602eef1bfbaae919a713bb1aa0508d53e591a0d693e","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"PCS","frequency_raw":"12/12","hpo_id":"HP:0001975","is_excluded":false,"label":"Decreased platelet glycoprotein IIb-IIIa","onset_id":null,"reference":"PMID:2014236","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c29784122b8b307577614461bcb000c7baa96e7bd859a562caff6ad5f5d61ecb","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003010","is_excluded":false,"label":"Prolonged bleeding time","onset_id":null,"reference":"OMIM:273800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c5818ab8c58dbe8d46de98e9e138f2f8e74a001e6898d5dfad4d8e070f0c5741","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000978","is_excluded":false,"label":"Bruising susceptibility","onset_id":null,"reference":"OMIM:273800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"d1c4909815fad946afe4020388fb4b03fd4b73f2c223907578a89ba814027248","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0100309","is_excluded":false,"label":"Subdural hemorrhage","onset_id":null,"reference":"PMID:8282784","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"eeab80e8c26e87bc31cc25c1c895fd5a8f5c41091a9a04b45fc882efb1168d94","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000979","is_excluded":false,"label":"Purpura","onset_id":null,"reference":"OMIM:273800","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"fbeeb23d0f8f9c6934d0c076fe189dd3a2bbbbda42dcc3eff510a7afbcc45383","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:273800","disease_name":"Glanzmann thrombasthenia","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0011871","is_excluded":true,"label":"Impaired ristocetin-induced platelet aggregation","onset_id":null,"reference":"PMID:8282784","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0031332\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>https://clinicalgenome.org/affiliation/40028/, https://orcid.org/0000-0002-7437-8060, PMID:1702098, PMID:9473221</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A platelet type bleeding disorder characterized by lifelong mucocutaneous bleeding, markedly impaired platelet aggregation, and absent or severely reduced clot retraction due to failure of the αIIbβ3 integrin complex to bind fibrinogen. Platelets appear normal in number and morphology, but aggregation responses to physiologic agonists (including ADP, collagen, epinephrine, and thrombin) are severely decreased or absent, while ristocetin‑induced agglutination remains normal. Biallelic loss‑of‑function ITGA2B variants reduce or abolish surface expression of the αIIbβ3 receptor, preventing fibrinogen‑mediated platelet bridging and producing the classic Glanzmann thrombasthenia phenotype.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0031332\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"glanzmann-thrombasthenia-1","sourceDocuments":[{"name":"MONDO: Glanzmann thrombasthenia 1","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0031332"}],"sourceNote":"","synonyms":["BDPLT2","bleeding disorder, platelet-type, 2","deficiency of GP 2B 3A complex","Diacyclothrombopathia 2B 3A","Glanzmann thrombasthenia type A","GT","ITGA2B-related Glanzmann thrombasthenia","Platelet glycoprotein 2B 3A deficiency","platelet glycoprotein IIb-IIIa deficiency","thrombasthenia","thrombasthenia of Glanzmann and Naegeli"],"takeawayHtml":"","title":"Glanzmann thrombasthenia 1"},"schemaVersion":1}
